Stroke trials are much more difficult to recruit for as opposed...

Stroke trials are much more difficult to recruit for as opposed to drug trials with existing populations ready to participate. The type of stroke and the time taken to assess the extent of the stroke at emergency ward could factor in how many successful dosings are implemented.

I was surprised by how quickly the first 5 were dosed, using Clinuvel as a reference when they held two trials for ischemic stroke the recruitment timeline took a while to complete.

If AGN announce the next milestone shortly I'd say they are making very good progress and would seem reasonable to expect they might complete the trial on time by the end of 2025. Hopefully we get some interim results 4Q or early 2025.